Patients with alcohol-related liver cancer do not live as long as patients with liver cancer that is not associated with alcohol consumption, a new study suggests.
The findings suggest that patients with alcohol-related liver cancer have a reduced overall survival time mainly due to worse liver function and tumor characteristics at diagnosis.
Hepatitis C Virus Screening Rates Low Despite Increase in Liver Cancer Rates
Hepatitis C virus screening rates remain low in the United States despite the steady increase of liver cancer incidence.
Advertisement
‘Efforts should be made to improve early liver cancer screening and alcohol abuse management to prevent people from being too late.
’
Tweet it Now
Liver cancer is the second leading cause of cancer-related deaths worldwide, with hepatitis B and C infections being the main causes.
"To improve the prognosis of liver cancer in the alcoholic population, efforts should be made to implement effective screening programmes for both cirrhosis and liver cancer, and to improve access to alcoholism treatment services," said co-author Charlotte Costentin from the Hôpital Henri-Mondor in France.
![New Way to Kill Liver Cancer]( "New Way to Kill Liver Cancer")
Silencing a key cellular enzyme and treating cells with a diabetes drug, a successful strategy for cancer therapy.
To compare aspects of alcohol-related and non-alcohol-related liver cancer for the study, published in the journal Cancer, researchers examined 894 patients with newly diagnosed liver cancer who were followed for five years. As many as 582 patients had a history of chronic alcohol abuse, and 312 did not.
They also recorded whether patients with alcohol-related liver cancer were abstinent or not at the time of cancer diagnosis.
A total of 601 patients had died by the time of the investigator's final analyses.
Alcohol-related liver cancers were more likely to be diffuse and were detected in patients with worse liver function. Median overall survival was 9.7 versus 5.7 months in the non-alcohol-related and alcohol-related groups respectively.
When researchers looked at each stage of cancer individually, however, survival was similar in patients with non-alcohol related and alcohol-related cancer.
The findings indicate that efforts should be made to improve both screenings for early signs of liver cancer and the management of alcohol abuse, the researcher said.
Source: IANS
New Way to Kill Liver Cancer
Silencing a key cellular enzyme and treating cells with a diabetes drug, a successful strategy for cancer therapy.
Advertisement
To compare aspects of alcohol-related and non-alcohol-related liver cancer for the study, published in the journal Cancer, researchers examined 894 patients with newly diagnosed liver cancer who were followed for five years. As many as 582 patients had a history of chronic alcohol abuse, and 312 did not.
They also recorded whether patients with alcohol-related liver cancer were abstinent or not at the time of cancer diagnosis.
A total of 601 patients had died by the time of the investigator's final analyses.
Alcohol-related liver cancers were more likely to be diffuse and were detected in patients with worse liver function. Median overall survival was 9.7 versus 5.7 months in the non-alcohol-related and alcohol-related groups respectively.
When researchers looked at each stage of cancer individually, however, survival was similar in patients with non-alcohol related and alcohol-related cancer.
The findings indicate that efforts should be made to improve both screenings for early signs of liver cancer and the management of alcohol abuse, the researcher said.
Source: IANS
Blocking A Protein That Stimulates Fat Synthesis May Help Treat Liver Cancer
The accumulation of fatty acids and lipids in the liver is one of the major causes of hepatocellular carcinoma or liver cancer.
Advertisement
 Scientists Discover How to Switch Liver Cancer Cell GrowthThe liver cancer cell line is an important cell line for the pharmaceutical industry for testing anti-cancer drugs. | Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
